サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1634202

酸化ストレスアッセイの世界市場 - 2025年～2033年

Global Oxidative Stress Assay Market - 2025 - 2033

出版日
ページ情報
英文 157 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
酸化ストレスアッセイの世界市場 - 2025年～2033年
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 157 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の酸化ストレスアッセイ市場は、2024年に11億8,000万米ドルに達し、2032年には19億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは9.7%で成長します。

一般に鎮痛剤として知られる酸化ストレスアッセイは、痛みを和らげるために開発された薬剤です。鎮痛剤は、体内の痛みのシグナルをブロックしたり、脳がそのシグナルを解釈する方法を変えたりすることで効果を発揮します。これらの薬には、市販薬から処方薬までさまざまな種類があります。これらの薬は、経口、非経口、局所的に服用することができます。

市場力学：

促進要因と抑制要因

疾患発症における酸化ストレスに対する認識の高まり

疾患発症における酸化ストレスに対する認識の高まりは、酸化ストレスアッセイ市場の成長を促進する主な要因です。がん、心血管疾患、糖尿病、神経変性疾患など、さまざまな慢性疾患の発症と進行において酸化ストレスが果たす極めて重要な役割が科学研究によって明らかにされ続けているため、全体的な健康管理における酸化ストレスの重要性に対する認識が高まっています。このような理解の高まりにより、患者の酸化的損傷を正確に測定・監視できる酸化ストレスアッセイなどの診断ツールに対する需要が急増しています。

酸化ストレスの初期徴候を特定することで、これらのアッセイは疾病メカニズムに関する貴重な洞察を提供し、ヘルスケア提供者が予防、治療、疾病管理に関してより多くの情報に基づいた決定を下すのに役立ちます。その結果、酸化ストレスが疾患の発症に果たす役割に対する認識が高まり、研究および臨床の両方の場面でこれらのアッセイの採用が拡大し、市場の拡大に寄与しています。

代替法との競合の激化

世界の酸化ストレスアッセイ市場は、研究者や臨床医により魅力的な選択肢を提供する代替法の出現により、課題に直面することが予想されます。診断技術の進歩に伴い、バイオマーカーアッセイやイメージング技術などの代替法の人気が高まっています。これらの方法は、酸化ストレスを間接的に、あるいは異なる生物学的経路を通じて評価することが可能であり、従来の酸化ストレスアッセイと比較して、納期が短縮され、ワークフローが簡素化されることが多いです。このような代替検査法への嗜好のシフトは、従来の酸化ストレスアッセイから注目とリソースをそらす可能性があり、酸化ストレスアッセイ市場が成長の勢いを維持することを困難にします。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 疾患発症における酸化ストレスへの意識の高まり
    • 抑制要因
      • 代替手段による競合の激化
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 製品別

  • 消耗品
  • 機器
  • キット
  • サービス

第7章 テストの種類別

  • 間接アッセイ
  • 抗酸化能アッセイ
  • 酵素ベースのアッセイ
  • 活性酸素種（ROS）ベースのアッセイ

第8章 技術別

  • 酵素免疫測定法（ELISA）
  • クロマトグラフィー
  • フローサイトメトリー
  • 顕微鏡検査
  • ハイコンテントスクリーニング
  • ラベルフリー検出技術

第9章 疾患タイプ別

  • 心血管疾患
  • 糖尿病
  • 慢性閉塞性肺疾患（COPD）
  • がん
  • 喘息

第10章 エンドユーザー別

  • 製薬会社
  • バイオテクノロジー企業
  • 臨床検査室
  • 学術調査機関
  • 契約調査機関
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第13章 企業プロファイル

  • Abcam, plc.
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • Enzo Biochem, Inc.
  • AMS Biotechnology Ltd.
  • Cell Biolabs, Inc.
  • Promega Corporation
  • Cayman Chemical
  • Eagle Biosciences, Inc.
  • Arbor Assays
  • Kamiya Biomedical Company
  • Genox Corporation

第14章 付録

第15章 問い合わせ

目次
Product Code: BT4826

The global oxidative stress assay market reached US$ 1.18 billion in 2024 and is expected to reach US$ 1.9 billion by 2032, growing at a CAGR of 9.7% during the forecast period 2025-2032.

Oxidative Stress Assays, commonly known as painkillers, are a class of drugs designed to relieve pain. They work by blocking pain signals in the body or by altering the way the brain interprets those signals. These medications come in various forms, ranging from over-the-counter to prescription medications. These medications can be taken orally, parenterally, and topically.

Market Dynamics: Drivers & Restraints

Increasing awareness of oxidative stress in disease pathogenesis

Increasing awareness of oxidative stress in disease pathogenesis is a major driver for the growth of the oxidative stress assay market. As scientific research continues to uncover the pivotal role oxidative stress plays in the development and progression of various chronic diseases, including cancer, cardiovascular conditions, diabetes, and neurodegenerative disorders, there is a growing recognition of its significance in overall health management. This increased understanding has led to a surge in demand for diagnostic tools, such as oxidative stress assays, that can accurately measure and monitor oxidative damage in patients.

By identifying early signs of oxidative stress, these assays provide valuable insights into disease mechanisms, helping healthcare providers make more informed decisions regarding prevention, treatment, and disease management. As a result, the increasing awareness of oxidative stress's role in disease pathogenesis is fueling greater adoption of these assays in both research and clinical settings, contributing to the market's expansion.

Rising competition from alternative methods

The global oxidative stress assays market is expected to face challenges due to the emergence of alternative methods that offer researchers and clinicians more appealing options. As diagnostic technologies advance, alternatives such as biomarker assays and imaging techniques are becoming increasingly popular. These methods can evaluate oxidative stress indirectly or through different biological pathways, often resulting in faster turnaround times and simpler workflows compared to traditional oxidative stress assays. This shift in preference towards alternative testing methods can divert attention and resources away from conventional oxidative stress assays, making it difficult for the oxidative stress assays market to maintain its growth momentum.

Segment Analysis

The global oxidative stress assay market is segmented based on product, test type, technology, disease type, end-user, and region.

Type:

Indirect assay segment is expected to dominate the global oxidative stress assay market share

The indirect assay segment is anticipated to lead the oxidative stress market, driven by several compelling advantages that make them highly appealing for both clinical and research applications. Indirect assays assess oxidative stress by detecting biomarkers, such as lipid peroxides, protein carbonyls, and DNA adducts, which are byproducts of oxidative damage. These assays are typically simpler, more cost-effective, and easier to conduct than direct assays that measure reactive oxygen species (ROS) directly. Consequently, indirect assays are frequently utilized in routine testing and large-scale studies, where affordability and ease of use are essential.

Additionally, indirect assays are particularly valuable for monitoring chronic conditions, as they can provide insights into long-term oxidative damage. This capability is critical for assessing the progression of diseases associated with oxidative stress. The growing preference for biomarker-based diagnostics, combined with the increasing adoption of these assays, is expected to propel their market share.

Furthermore, innovations in reagent development and the automation of testing processes are improving the sensitivity, throughput, and scalability of indirect assays, further solidifying their dominant position in the market. With their affordability, ease of use, and reliable results, indirect assays are well-positioned to drive the continued growth of the oxidative stress testing market.

Geographical Analysis

North America is expected to hold a significant position in the global oxidative stress assay market share

North America is expected to maintain a dominant position in the oxidative stress assay market due to several key factors. The region has a high level of investment in medical research, which fosters the development and adoption of advanced diagnostic tools, including oxidative stress assays. The presence of major pharmaceutical and biotechnology companies in the U.S. and Canada also contributes to the rapid development and commercialization of innovative assays for oxidative stress measurement.

Additionally, the rising prevalence of chronic diseases, such as cardiovascular diseases, diabetes, cancer, and neurodegenerative disorders, in North America is driving demand for reliable diagnostic tools that can monitor oxidative stress, a key factor in the progression of these diseases. As the focus on personalized medicine and preventative healthcare grows, the demand for biomarkers and assays to assess oxidative damage is expected to increase, further fueling market growth.

Moreover, North America benefits from strong regulatory frameworks and well-established research and clinical standards, making it easier to introduce and adopt new assays. The region's advanced technological capabilities also support the continuous improvement of assay sensitivity and accuracy, providing a competitive edge. With increasing awareness of oxidative stress's role in disease pathogenesis and ongoing advancements in diagnostic technology, North America is poised to remain a leading market for oxidative stress assays in the coming years.

Competitive Landscape

The major global players in the oxidative stress assay market include Bayer AG, Teva Pharmaceuticals USA, Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin, Cipla, Sanofi, AdvaCare Pharma, Wellona Pharma, and Montage Laboratories Pvt. Ltd. among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Oxidative Stress Assays market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Test Type
  • 3.3. Snippet by Technology
  • 3.4. Snippet by Disease Type
  • 3.5. Snippet by End-user
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing awareness of oxidative stress in disease pathogenesis
    • 4.1.2. Restraints
      • 4.1.2.1. Rising competition from alternative methods
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Product

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. Consumables*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Instruments
  • 6.4. Kits
  • 6.5. Services

7. By Test Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 7.1.2. Market Attractiveness Index, By Test Type
  • 7.2. Indirect Assays*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Antioxidant Capacity Assays
  • 7.4. Enzyme-based Assays
  • 7.5. Reactive Oxygen Species (ROS)-based Assays

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Enzyme-linked Immunosorbent Assay (ELISA)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Chromatography
  • 8.4. Flow Cytometry
  • 8.5. Microscopy
  • 8.6. High-Content Screening
  • 8.7. Label-free Detection Technology

9. By Disease Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 9.1.2. Market Attractiveness Index, By Disease Type
  • 9.2. Cardiovascular Disease*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diabetes
  • 9.4. Chronic Obstructive Pulmonary Disease (COPD)
  • 9.5. Cancer
  • 9.6. Asthma

10. By End-user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.1.2. Market Attractiveness Index, By End-user
  • 10.2. Pharmaceutical Companies*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Biotechnology Companies
  • 10.4. Clinical Laboratories
  • 10.5. Academic & Research Institutes
  • 10.6. Contract Research Organizations
  • 10.7. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Abcam, plc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Enzo Biochem, Inc.
  • 13.3. AMS Biotechnology Ltd.
  • 13.4. Cell Biolabs, Inc.
  • 13.5. Promega Corporation
  • 13.6. Cayman Chemical
  • 13.7. Eagle Biosciences, Inc.
  • 13.8. Arbor Assays
  • 13.9. Kamiya Biomedical Company
  • 13.10. Genox Corporation

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services

15. Contact Us